IVONESCIMAB
Clinical trials for IVONESCIMAB explained in plain language.
Never miss a new study
Get alerted when new IVONESCIMAB trials appear
Sign up with your email to follow new studies for IVONESCIMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for advanced kidney cancer: ivonescimab trial launches
Disease control Recruiting nowThis study tests a drug called ivonescimab in 40 people with advanced clear cell kidney cancer that has spread or cannot be removed. Participants must have already tried at least one other treatment. The goal is to see if ivonescimab can help control the cancer and to check for s…
Matched conditions: IVONESCIMAB
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 07:22 UTC
-
New drug combo shows promise in shrinking esophageal tumors before surgery
Disease control Recruiting nowThis study is testing a new drug called ivonescimab (AK112) combined with two chemotherapy drugs (albumin-paclitaxel and cisplatin) given before surgery for people with advanced esophageal cancer that can be removed. The goal is to see if this combination can shrink tumors enough…
Matched conditions: IVONESCIMAB
Phase: PHASE1, PHASE2 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated May 26, 2026 07:21 UTC